Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-004074·Dianthus Therapeutics, Inc. /DE/
Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, par value $0.001 per share · CUSIP: 252828108
Event date: 2025-09-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 2,121,140.00 · Class: 5.3%
- Point72 Capital Advisors, Inc.
Shares: 2,121,140.00 · Class: 5.3%
- Steven A. Cohen
Shares: 2,121,140.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004074
- Form type
- SCHEDULE 13G
- Filer
- Dianthus Therapeutics, Inc. /DE/
- CIK
- CIK 1690585
- Filed
- Sep 12, 2025
- Reporting period
- Sep 11, 2025
- Description
- Schedule 13G beneficial ownership